The Importance of Inducible Nitric Oxide Synthase and Nitrotyrosine as Prognostic Markers for Oral Squamous Cell Carcinoma.

BACKGROUND The prognosis of human cancer depends on the deregulations of many molecular patterns. In recent years, a great interest in the intracellular signaling mechanisms related to nitric oxide (NO)-induced carcinogenesis has appeared, as one of the most preeminent prognostic markers for many types of neoplasms. In this study, we identify the levels of iNOS and nitrotyrosine in sample of normal oral mucosa (NOM), oral leukoplakia (OL), and oral squamous cell carcinoma (OSCC). METHODS Quantitative polymerase chain reactions (qPCRs) were utilized to detect the NOS2 levels in fresh-frozen tissue samples of NOM (n = 6), OL (n = 20), and OSCC (n = 15). Moreover, the immunohistochemical method was used to examine the levels of iNOS and nitrotyrosine in 85 cases of OSCC (39 cases without metastases and 46 with metastases), 42 cases of OL, and 16 cases of NOM. RESULTS There are rising tendencies in the iNOS mRNA and protein levels during human oral carcinogenesis. Similar findings were obtained in the nitrotyrosine staining. Furthermore, iNOS and nitrotyrosine immunostaining are associated with several clinical pathological features of OSCC (site, presence of metastasis, staging, recidivism, and survival). CONCLUSIONS The NO-signaling pathway plays a vital role in the development and progression of human oral dysplastic and neoplastic diseases. Nitrotyrosine were a significant marker for the discrimination of OSCC prognosis and survival. This article is protected by copyright. All rights reserved.

[1]  Xiaogang Zhang,et al.  Nitric oxide inhibits autophagy and promotes apoptosis in hepatocellular carcinoma , 2019, Cancer science.

[2]  D. Marković,et al.  Oxidative and nitrosative stress in myeloproliferative neoplasms: the impact on the AKT / mTOR signaling pathway. , 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[3]  S. Warnakulasuriya,et al.  Prevalence of oral potentially malignant disorders: A systematic review and meta‐analysis , 2018, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[4]  BasudharDebashree,et al.  Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression. , 2017 .

[5]  F. Howe,et al.  Investigating the role of tumour cell derived iNOS on tumour growth and vasculature in vivo using a tetracycline regulated expression system , 2016, International journal of cancer.

[6]  Lvhua Guo,et al.  The Expression and Correlation of iNOS and p53 in Oral Squamous Cell Carcinoma , 2015, BioMed Research International.

[7]  I. Singh,et al.  S-nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma☆ , 2015, Redox biology.

[8]  E. Gherlone,et al.  Nitric oxide synthase evaluation in oral precancerous and cancerous lesions. , 2014, Journal of biological regulators and homeostatic agents.

[9]  A. Tegginamani,et al.  Do tobacco stimulate the production of nitric oxide by up regulation of inducible nitric oxide synthesis in cancer: Immunohistochemical determination of inducible nitric oxide synthesis in oral squamous cell carcinoma--a comparative study in tobacco habituers and non-habituers. , 2014, Journal of cancer research and therapeutics.

[10]  P. Tarapore,et al.  Site-specific S-nitrosylation of integrin α6 increases the extent of prostate cancer cell migration by enhancing integrin β1 association and weakening adherence to laminin-1. , 2012, Biochemistry.

[11]  V. Kahya,et al.  Impact of Smoking on p65 Nuclear Factor &kgr;B, p38 Mitogen-Activated Protein Kinase, and Inducible Nitric Oxide Synthase Expression Levels in Oral Mucosa , 2012, The Journal of craniofacial surgery.

[12]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[13]  J. Zwang,et al.  Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation. , 2009, Medicina oral, patologia oral y cirugia bucal.

[14]  Wei‐liang Chen,et al.  Effect of using RNA interference to alter iNOS gene expression on the proliferation of tongue squamous cell carcinoma cell line Tca8113. , 2008, The British journal of oral & maxillofacial surgery.

[15]  M. Quintero,et al.  Inducible nitric oxide synthase: Correlation with extracapsular spread and enhancement of tumor cell invasion in head and neck squamous cell carcinoma , 2008, Head & neck.

[16]  Philip Sloan,et al.  Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. , 2006, Oral oncology.

[17]  Yuk-Kwan Chen,et al.  Inhibitory effect of inducible nitric oxide synthase inhibitors on DMBA-induced hamster buccal-pouch squamous-cell carcinogenesis. , 2005, Nitric oxide : biology and chemistry.

[18]  Sang‐Gun Ahn,et al.  Sequential expression of inducible nitric oxide synthase and cyclooxygenase-2 during DMBA-induced hamster buccal pouch carcinogenesis. , 2004, In vivo.

[19]  K. Harada,et al.  Overexpression of iNOS gene suppresses the tumorigenicity and metastasis of oral cancer cells. , 2004, In vivo.

[20]  Yuk-Kwan Chen,et al.  Increased expression of inducible nitric oxide synthase for human buccal squamous‐cell carcinomas: Immunohistochemical, reverse transcription–polymerase chain reaction (RT‐PCR) and in situ RT‐PCR studies , 2002, Head & neck.

[21]  Yuk-Kwan Chen,et al.  Expression of inducible nitric oxide synthase in human oral premalignant epithelial lesions. , 2002, Archives of oral biology.

[22]  G. Gores,et al.  Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[23]  P. Brennan,et al.  Does expression of inducible nitric oxide synthase correlate with severity of oral epithelial dysplasia? , 2000, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[24]  W P Bennett,et al.  Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. , 1999, Journal of the National Cancer Institute.

[25]  C. Harris,et al.  Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. , 1998, British Journal of Cancer.

[26]  M. Weissler,et al.  Immunohistochemical characterizationof nitric oxide synthase activity in squamous cell carcinoma of the head and neck , 1995 .

[27]  S Detre,et al.  A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. , 1995, Journal of clinical pathology.

[28]  S. Ambs,et al.  Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression. , 2017, Antioxidants & redox signaling.

[29]  S. Varghese,et al.  Expression of inducible nitric oxide synthase (iNOS) in oral precancer and oral squamous cell carcinoma: an immunohistochemical study. , 2010, Cancer biomarkers : section A of Disease markers.